Dr. Scott Aaronson, MD
Claim this profileSheppard Pratt Health System
Studies Depression
Studies Major Depressive Disorder
7 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Scott Aaronson, MD is currently running
VNS
for Bipolar Depression
This trial is testing whether VNS Therapy, which sends electrical impulses to the vagus nerve, can reduce depression symptoms in patients who haven't responded to other treatments. The study will observe the effects of VNS therapy over a year. Vagus nerve stimulation (VNS) is a recognized treatment for severe treatment-resistant depression and has shown promising results.
Recruiting0 awards N/A7 criteria
Psilocybin
for Treatment-Resistant Depression
This trial is testing a new medication called COMP360 to help people with severe depression that hasn't improved with other treatments. The study involves adults aged 18 and older. Researchers want to see if a single dose of COMP360 can reduce depression symptoms when given with psychological support.
Recruiting1 award Phase 312 criteria
More about Scott Aaronson, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Scott Aaronson, MD has experience with
- Psilocybin
- Phone Application (Mood App)
- Wearable, Multi-sensor Device (Verily Study Watch)
- Relivion®DP
- COMP360 Psilocybin Therapy
- Niacin
Breakdown of trials Scott Aaronson, MD has run
Depression
Major Depressive Disorder
Osteopenia
Anorexia Nervosa
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott Aaronson, MD specialize in?
Scott Aaronson, MD focuses on Depression and Major Depressive Disorder. In particular, much of their work with Depression has involved treating patients, or patients who are undergoing treatment.
Is Scott Aaronson, MD currently recruiting for clinical trials?
Yes, Scott Aaronson, MD is currently recruiting for 3 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Scott Aaronson, MD has studied deeply?
Yes, Scott Aaronson, MD has studied treatments such as Psilocybin, Phone application (Mood App), Wearable, multi-sensor device (Verily Study Watch).
What is the best way to schedule an appointment with Scott Aaronson, MD?
Apply for one of the trials that Scott Aaronson, MD is conducting.
What is the office address of Scott Aaronson, MD?
The office of Scott Aaronson, MD is located at: Sheppard Pratt Health System, Baltimore, Maryland 21044 United States. This is the address for their practice at the Sheppard Pratt Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.